[December 12th] Visualization of complex connections between genes, diseases, molecules, etc. that are indispensable for drug discovery research Introduction of R&D support tools using AI that can lead to the discovery of unknown information | FRONTEO, Inc. | Providing business solutions with development AI

Company Info

Recruit

Top > concept encoder, Event / Seminar

[Held on December 12] Visualization of complex connections of genes, diseases, molecules, etc. that are indispensable for drug discovery research Introducing R & D support tools that utilize AI, which also leads to the discovery of unknown information

concept encoder, Event / Seminar

2021/12/8

Have you ever thought that searching for a target in the drug discovery process is like "searching for a needle in hay", searching for limited information from a huge amount of paper data?Also, have you ever felt that the problem of information search by humans is that there is a limit to the amount of work and there is a risk that it will be a personal approach, and it is difficult to make a comprehensive analysis.
In this seminar, based on the dissertation information, information on molecules and genes related to the disease to be analyzed will be visualized in the form of a pathway map (route map showing the relationship) to improve the efficiency and optimization of the target compound candidate search process. Introducing the AI that performs

Click here to apply:https://lp.fronteo.com/BP-WBN-20211215-LSAI_Registration.html

【Webinar Summary】

◆ Theme: Visualize complex connections of genes, diseases, molecules, etc. that are indispensable for drug discovery research Introducing R & D support tools that utilize AI, which also leads to the discovery of unknown information
◆ Date: September 2021, 12 (Wednesday) 15: 17-00: 17

◆ Recommended for people like this!

・ Those who work for a pharmaceutical company
・ Those who think that the drug discovery process will be streamlined with AI
・ Those involved in drug discovery research

please use this form.

Speakers/panelist:

Keiichiro Yoshimoto (FRONTEO Life Science AI Business Headquarters)　

After joining Mitsubishi Tanabe Pharma (formerly Mitsubishi Tanabe Pharma), he engaged in overseas business development and was in charge of out-licensing and marketing of cardiovascular drugs in emerging regions centered on Asia.After that, he was in charge of domestic and overseas business development of functional chemicals at Kao and Sumitomo Chemical, and was assigned overseas as a sales manager. Since 2016, he has participated in the establishment of a pharmaceutical venture company and launched several new businesses as a business manager in the animal health field.
Joined FRONTEO in 2021.Currently, the business development team of the Life Science AI Business Headquarters is working on new business development.

Share this article

0
Facebook
Twitter

<To the previous article

To the next article>

Share this article

0
Facebook
Twitter

Articles in the same category

[Online seminar held on 5/30] Practical techniques for legal due diligence for M&A

[5/31 15th Fraud Countermeasures Study Session] [Must-see for compliance personnel] Mass media response in the event of a crisis

[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -

[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~

Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI

Searching for therapeutic targets for pancreatic cancer - I tried using paper search AI -

Parkinson's disease - Analyzing drug discovery targets using paper search AI

Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th

Searching for new targets for sporadic ALS using AI: Become friends with AI